DTGM fusion protein
Term · Oncology and biomedicine · MLC-T-ONC-002601
An anticancer drug formed by the combination of diphtheria toxin and a colony-stimulating factor (GM-CSF). The colony-stimulating factor is attracted to cancer cells, and the diphtheria toxin kills the cells.
| Identifier | MLC-T-ONC-002601 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002601",
"term": "DTGM fusion protein",
"field": "Oncology and biomedicine",
"definition": "An anticancer drug formed by the combination of diphtheria toxin and a colony-stimulating factor (GM-CSF). The colony-stimulating factor is attracted to cancer cells, and the diphtheria toxin kills the cells.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/dtgm-fusion-protein/"
}
Record 6,265 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.